🔎 Trials Near Me

Home › Heart Attack › Michigan

Heart Attack clinical trials in Michigan

6 studies for Heart Attack are looking for participants at sites in Michigan.

Cities in Michigan

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

  • Paragon Health, Inc, Kalamazoo
  • Michigan Kidney Consultants, PC, Pontiac
  • St. Clair Nephrology Research, Roseville
  • and 1 more
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05485961

An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

  • Henry Ford Hospital, Detroit
  • AA Medical Research Center, Flint
  • Metro Health Univ of MI Health, Wyoming
RecruitingPhase 3
Ages 18 to 100 · All sexes · Updated Sep 4, 2026 · NCT07517263

OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

  • Henry Ford Health System, Detroit
  • Healthy Heart Cardiology, Grand Rapids
  • MyMichigan Medical Center Midland - Clinical Research Department, Midland
  • and 2 more
RecruitingPhase 3
Ages 50 to 105 · All sexes · Updated Aug 21, 2026 · NCT07136012

AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor

  • Henry Ford Hospital, Detroit
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Jun 1, 2026 · NCT06699056

Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk

  • Henry Ford Health System, Detroit
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Mar 24, 2026 · NCT04774159

Focused Orticumab Research for Treating Inflammation in Coronary Arteries

  • Abcentra Investigational Site, Midland
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jan 27, 2026 · NCT06927739

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.